(NYSE: BMY) Bristol Myers Squibb Co's forecast annual revenue growth rate of -5.47% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.99%.
Bristol Myers Squibb Co's revenue in 2026 is $50,033,000,000.On average, 30 Wall Street analysts forecast BMY's revenue for 2026 to be $103,710,782,807,447, with the lowest BMY revenue forecast at $100,066,177,770,774, and the highest BMY revenue forecast at $108,594,103,857,706. On average, 30 Wall Street analysts forecast BMY's revenue for 2027 to be $100,806,136,841,596, with the lowest BMY revenue forecast at $94,577,807,314,539, and the highest BMY revenue forecast at $107,680,397,491,249.
In 2028, BMY is forecast to generate $83,827,959,929,310 in revenue, with the lowest revenue forecast at $75,657,748,862,803 and the highest revenue forecast at $98,373,674,702,706.